Display options
Share it on

Clin Pediatr Endocrinol. 2010 Oct;19(4):91-9. doi: 10.1297/cpe.19.91. Epub 2010 Dec 29.

One Novel and Two Recurrent THRB Mutations Associated with Resistance to Thyroid Hormone: Structure-based Computational Mutation Prediction.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology

Satoshi Narumi, Hideo Cho, Izumi Tamada, Yuki Kozu, Takayoshi Tsuchiya, Toshiro Nagai, Tomonobu Hasegawa

Affiliations

  1. Department of Pediatrics, Keio University School of Medicine, Tokyo, Japan.

PMID: 23926384 PMCID: PMC3687625 DOI: 10.1297/cpe.19.91

Abstract

Inactivating mutations of THRB, which encodes the thyroid hormone receptor β (TRβ), cause resistance to thyroid hormone (RTH; OMIM 190160). To date, more than 100 THRB mutations have been reported among RTH patients. Most mutations substitute a single amino-acid residue in the ligand-binding domain. In this report, we describe clinical and molecular findings of three families with RTH. Three families harbored one novel (p.I431M) and two recurrent (p.R320H and p.R383C) THRB mutations. To examine the pathogenicity of identified mutations, we introduced a novel computational mutation prediction method based on three-dimensional structure data of TRβ-T3 complex. First, to define the accuracy of our prediction system, we evaluated ten previously reported 'positive control' mutations, as well as 30 seemingly benign sequence variations observed among vertebral species as 'negative controls'. We found that our system had a sensitivity of 80% and a specificity of 93%. We then analyzed three mutations detected in the present study and found that all three mutations are predicted to be deleterious. Our data suggest that our structure-based prediction system would be a prompt, inexpensive and feasible method for evaluating the pathogenicity of missense THRB mutations.

Keywords: computational biology; genetics; mutation; thyroid hormone receptor beta; thyroid hormone resistance syndrome

References

  1. J Clin Endocrinol Metab. 1967 Feb;27(2):279-94 - PubMed
  2. J Clin Endocrinol Metab. 1997 Oct;82(10):3246-50 - PubMed
  3. J Clin Ultrasound. 2004 Feb;32(2):82-5 - PubMed
  4. J Clin Endocrinol Metab. 1992 May;74(5):1164-70 - PubMed
  5. Ann Intern Med. 1995 Oct 15;123(8):572-83 - PubMed
  6. Endocr Rev. 1993 Jun;14(3):348-99 - PubMed
  7. J Clin Invest. 1993 Jun;91(6):2408-15 - PubMed
  8. Clin Endocrinol (Oxf). 2009 Apr;70(4):650-4 - PubMed
  9. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8977-81 - PubMed
  10. N Engl J Med. 1982 Mar 18;306(11):635-9 - PubMed
  11. J Clin Endocrinol Metab. 1997 May;82(5):1608-14 - PubMed
  12. Rev Endocr Metab Disord. 2000 Jan;1(1-2):97-108 - PubMed
  13. Nat Rev Genet. 2008 Feb;9(2):141-51 - PubMed
  14. J Clin Invest. 1994 Aug;94(2):506-15 - PubMed
  15. J Mol Biol. 2006 Jul 14;360(3):586-98 - PubMed

Publication Types